Though cervical cancer is dangerous, it has a clear vulnerable window. It takes 6 to 8 years for mild cervical inflammation to progress into malignant lesions. If this window is seized, modern medical screening can detect precancerous lesions in a timely manner and deliver targeted treatment to help women restore full health.
Research shows the five-year survival rate reaches 80%–90% for Stage I cervical cancer, 60%–70% for Stage II, 40%–50% for Stage III, and only 10% for Stage IV. This highlights that routine screening and prompt treatment are critically important.
Many women hold the misconception that “I eat and sleep well, so I cannot have serious illnesses.” In reality, cervical cancer produces almost no discomfort in its early stages. By the time irregular vaginal bleeding appears, the disease has usually advanced to Stage II with greatly elevated risks. Gynecologists from Shanghai Ren'ai Hospital recommend annual gynecological checkups for all women to detect lesions early and secure more treatment options.
Per US medical guidelines, sexually active women should receive annual cervical cytology Pap smears starting at age 18. Those with three consecutive normal results may extend the screening interval to once every two years. Current cervical early-detection technology is mature: annual screening for adult women can clearly identify abnormal cervical cells. If lesions are found at this stage, surgery and radiotherapy can halt cancer spread, avoid radical removal of the uterus and ovaries required for advanced cancer (which severely impairs quality of life), and deliver excellent long-term prognosis.
Nowadays, many Chinese women adopt lifestyles similar to Western women. Regular gynecological screening is standard practice in Western countries, yet numerous Chinese women skip essential tests entirely. Many young women only seek medical care after obvious symptoms develop — by then, the optimal treatment window for most diseases has closed.
Health is akin to long-term savings: consistent healthy habits and routine checkups when young pay off in later life. Gynecological disorders are just as treatable as hepatitis or headaches. Avoiding screening out of embarrassment over intimate health only harms one’s own body. Young women cannot afford to be complacent, as experts observe a steady downward shift in the age of onset for malignant ovarian and uterine tumors. Routine gynecological screening serves as an indispensable health safeguard for women of all age groups.